Journal Mobile Options
Table of Contents
Vol. 25, No. 6, 2008
Issue release date: July 2008
Dement Geriatr Cogn Disord 2008;25:524–530
(DOI:10.1159/000131665)

Cerebral Substrates Related to Impaired Performance in the Clock-Drawing Test in Dementia with Lewy Bodies

Nagahama Y. · Okina T. · Suzuki N. · Matsuda M.
Department of Geriatric Neurology, Shiga Medical Center, Moriyama, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Aims: To identify the neural correlates of impaired performance in the clock-drawing test (CDT) in patients with dementia with Lewy bodies (DLB). Methods: Cerebral blood flow was measured by single photon emission computed tomography in patients with clinically diagnosed DLB, and was compared between impaired CDT (n = 30) and normal CDT (n = 30) subgroups. Results: DLB patients with impaired CDT performance showed significantly lower cerebral blood flow in the bilateral frontal eye fields, supplementary eye fields, right posterior putamen and the right ventrolateral part of the thalamus relative to the normal CDT subgroup. Performance in other visuospatial/attentional tasks (trail making test part A, copying a cube, semantic fluency, and block design) was also poorer in the impaired CDT group than the normal CDT group. Conclusions: This study indicates that impaired performances on the CDT and some visuospatial/attentional tasks by DLB patients are closely related to dysfunctions of the frontal-subcortical network relevant to control of visuospatial attention and arousal, involving the frontal eye fields, supplementary eye fields and the thalamus. Our findings provide evidence that cognitive performance in DLB reflects the pathological involvement of both cortical and subcortical regions, and suggest that the neurophysiological basis underlying impaired CDT in DLB may be different from that in Alzheimer disease.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O’Brien J, Playfer J, Reid W: Dementia with Lewy bodies. Lancet Neurol 2004;3:19–28.
  2. Collerton D, Burn D, McKeith I, O’Brien J: Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord 2003;16:229–237.
  3. Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ: Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2001;70:483–488.
  4. Cahn-Weiner DA, Williams K, Grace J, Tremont G, Westervelt H, Stern RA: Discrimination of dementia with Lewy bodies from Alzheimer disease and Parkinson disease using the clock drawing test. Cogn Behav Neurol 2003;16:85–92.
  5. Gnanalingham KK, Byrne EJ, Thornton A: Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 1996;347:696–697.
  6. Nagahama Y: Cognitive disturbance in dementia with Lewy bodies (in Japanese). Jpn J Geriatr Psychiatry 2006;17:400–407.
  7. Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M: Neural correlates of impaired performance on the clock drawing test in Alzheimer’s disease. Dement Geriatr Cogn Disord 2005;19:390–396.
  8. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124.
  9. McKeith IG, Perry EK, Perry RH: Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902–905.
  10. Shulman KI: Clock-drawing: Is it the ideal cognitive screening test? Int J Geriat Psychiatry 2000;15:548–561.
  11. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y: Motor signs during the course of Alzheimer disease. Neurology 2004;63:975–982.
  12. Nagahama Y, Okina T, Suzuki N, Matsuda M, Fukao K, Murai T: Classification of psychotic symptoms in dementia with Lewy bodies. Am J Geriatr Psychiatry 2007;15:961–967.
  13. Strub RL, Black FW: The Mental Status Examination in Neurology, ed 4, Philadelphia, F.A. Davis, 2000.
  14. Mazziotta JC, Toga AW, Evans A, Fox P, Lancaster J: A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage 1995;2:89–101.
  15. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping 1995;2:189–210.

    External Resources

  16. Bailey DL, Jones T, Friston KJ, Colebatch JG, Frackowiak RSJ: Physiological validation of statistical parametric mapping. J Cereb Blood Flow Metab 1991;11(suppl 3):S150.
  17. Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M: The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test. J Neurol Neurosurg Psychiatry 2005;76:169–175.
  18. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M: Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–289.
  19. Maldjian JA, Laurienti PJ, Burdette JH: Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004;21:450–455.
  20. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH: An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233–1239.
  21. Fan J, McCandliss BD, Fossella J, Flombaum JI, Posner MI: The activation of attentional networks. Neuroimage 2005;26:471–479.
  22. Gitelman DR, Nobre AC, Parrish TB, LaBar KS, Kim YH, Meyer JR, Mesulam M: A large-scale distributed network for covert spatial attention: further anatomical delineation based on stringent behavioural and cognitive controls. Brain 1999;122:1093–1106.
  23. Nachev P: Cognition and medial frontal cortex in health and disease. Curr Opin Neurol 2006;19:586–592.
  24. Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, LaFrance WC Jr, Coffey CE: Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002;14:377–405.
  25. Paus T: Location and function of the human frontal eye-field: a selective review. Neuropsychologia 1996;34:475–483.
  26. Grosbras MH, Lobel E, Van de Moortele PF, LeBihan D, Berthoz A: An anatomical landmark for the supplementary eye fields in human revealed with functional magnetic resonance imaging. Cereb Cortex 1999;9:705–711.
  27. Pierrot-Deseilligny C, Muri RM, Ploner CJ, Gaymard B, Rivaud-Pechoux S: Cortical control of ocular saccades in humans: a model for motricity. Prog Brain Res 2003;142:3–17.
  28. Astafiev SV, Shulman GL, Stanley CM, Snyder AZ, Van Essen DC, Corbetta M: Functional organization of human intraparietal and frontal cortex for attending, looking, and pointing. J Neurosci 2003;23:4689–4699.
  29. Kincade JM, Abrams RA, Astafiev SV, Shulman GL, Corbetta M: An event-related functional magnetic resonance imaging study of voluntary and stimulus-driven orienting of attention. J Neurosci 2005;25:4593–4604.
  30. Wardak C, Ibos G, Duhamel JR, Olivier E: Contribution of the monkey frontal eye field to covert visual attention. J Neurosci 2006;26:4228–4235.
  31. Bon L, Lucchetti C: Attention-related neurons in the supplementary eye field of the macaque monkey. Exp Brain Res 1997;113:180–185.
  32. Mosimann UP, Muri RM, Burn DJ, Felblinger J, O’Brien JT, McKeith IG: Saccadic eye movement changes in Parkinson’s disease dementia and dementia with Lewy bodies. Brain 2005;128:1267–1276.
  33. Bradshaw JM, Saling M, Anderson V, Hopwood M, Brodtmann A: Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer’s type and controls. J Neurol Neurosurg Psychiatry 2006;77:1129–1135.
  34. Jones BE: Arousal system. Front Biosci 2003;8:S438–S451.
  35. Paus T, Zatorre RJ, Hofle N, Caramanos Z, Gotman J, Petrides M, Evans AC: Time-related changes in neural systems underlying attention and arousal during the performance of an auditory vigilance task. J Cogn Neurosci 1997;9:392–408.
  36. Hofle N, Paus T, Reutens D, Fiset P, Gotman J, Evans AC, Jones BE: Regional cerebral blood flow changes as a function of delta and spindle activity during slow wave sleep in humans. J Neurosci 1997;17:4800–4808.
  37. Portas CM, Rees G, Howseman AM, Josephs O, Turner R, Frith CD: A specific role for the thalamus in mediating the interaction of attention and arousal in humans. J Neurosci 1998;18:8979–8989.
  38. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O’Brien JT, Ballard CG: Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia. Neurology 2000;54:1616–1624.
  39. LaBerge D: Attention, awareness, and the triangular circuit. Conscious Cogn 1997;6:149–181.
  40. Mai JK, Assheuer J, Paxinos G: Atlas of the Human Brain. San Diego, Academic Press, 1997.
  41. Zikopoulos B, Barbas H: Prefrontal projections to the thalamic reticular nucleus form a unique circuit for attentional mechanisms. J Neurosci 2006;26:7348–7361.
  42. Annoni JM, Khateb A, Gramigna S, Staub F, Carota A, Maeder P, Bogousslavsky J: Chronic cognitive impairment following laterothalamic infarcts: a study of 9 cases. Arch Neurol 2003;60:1439–1443.
  43. Karnath HO, Himmelbach M, Rorden C: The subcortical anatomy of human spatial neglect: putamen, caudate nucleus and pulvinar. Brain 2002;125:350–360.
  44. Amici S, Boxer AL: Oiling the gears of the mind – roles for acetylcholine in the modulation of attention; in Miller BL, Cummings JL (eds): The Human Frontal Lobes: Functions and Diseases, ed 2. New York, Guilford Press, 2007, pp 135–144.
  45. Perry E, Walker M, Grace J, Perry R: Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 1999;22:273–280.
  46. Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, Cicin-Sain A, Anand R, Spiegel R: Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 2002;13:183–192.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50